Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Belgium-Based FN America Plans Liberty, South Carolina, Manufacturing Plant

05/03/2023
FN America, the United States subsidiary of Belgium-based FN Herstal, S.A., a global firearms manufacturer, plans to establish a new production facility in Pickens County, South Carolina. The $33 million project is expected to create 176 jobs.

The approximately 100,000-square-foot plant will be constructed over two phases and will accommodate the company’s expanding manufacturing operations. Operations are scheduled for 2025.

“FN America has experienced significant growth over the last several years and demand for our products continues to increase in all market segments that we serve. Our new facility in Liberty, South Carolina will allow us to expand our manufacturing capabilities and grow our highly skilled workforce to meet that new demand. We are proud to partner with Pickens County and the state of South Carolina on this expansion,” said FN America, LLC President and Chief Executive Officer Mark Cherpes.

The Coordinating Council for Economic Development approved job development credits related to this project.

“When an existing employer chooses to expand within your state, their decision serves as an endorsement of the business environment and available talent. We’re proud to welcome FN America to the Upstate and look forward to their growth in Pickens County,” Upstate SC Alliance President and CEO John Lummus noted.

FN America’s primary business focuses on the design and production of a wide range of small arms including lightweight machine guns, medium machine guns and additional weapons for the U.S. Department of Defense. The company also produces firearms for law enforcement agencies as well as consumers.

Exclusive Research